independent

Monday 20 May 2013

Brandon links up with former partners to make fresh play in biotech sector 

Three Irish biomedical companies are investing €3m in a new joint venture to make the chemicals required to make biodegradable human implants. The joint venture reunites Alltracel founder Gerry Brandon, who runs chemicals maker Cellulac, with his former colleague there Tony Richardson, who is now chief executive of AIM-listed clinical research organisation Venn Life Sciences.

 

Don't Miss

More

Irish News